4
ESMO-MCBS v1.1
Scorecard version: 1
Indication details
- Tumour Type
- Thoracic Malignancies
- Tumour Sub-type
- Non-small-cell Lung Cancer
- Tumour stage
- Metastatic
- Combined Agent(s)
- Chemotherapy
- Control Arm
- Chemotherapy
- Treatment Setting
- 1st line treatment stage IV NSCLC ECOG<2
Primary Outcome(s)
- Primary Outcome(s)
- QoL
- Form(s)
- Form 2c
Outcome Data
- OS Control
- 8.9 months
- OS Gain
- 2.7 months
- OS HR
- HR for death in control arm 1.7 (1.14-2.54)
- QoL Comment
- Improved
Final Score (after adjustments)
- Preliminary non-curative score
- 4
- Final non-curative Score
- 4
DFS, disease-free survival; DoR, duration of response; EFS, event-free survival; HR, hazard ratio; ORR, overall response rate; OS, overall survival; pCR, pathologic complete response/remission; PFS, progression-free survival; QoL, quality of life; RFS, relapse-free survival; RR, response rate